Pfizer Inc on Friday presented promising results from a tiny early study of its experimental gene therapy for a rare muscle disease, but two of the six patients in the trial experienced side effects that landed them in the hospital.
from Reuters: Health News https://ift.tt/2IUZKA8
No comments:
Post a Comment